Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesOtorhinolaryngology (ENT)PacificSource Balloon Dilation Coverage | OpenPaye…
    Ask Trek AI about this page
    CurrentPacificSource Community SolutionsPolicy N/A

    Balloon Sinus Ostial Dilation and Eustachian Tube Dilation

    Customize your policy alerts

    Sign up for all pacificsourcecommunitysolutions policy alerts

    Know when pacificsourcecommunitysolutions releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage and medical-necessity criteria for balloon dilation of the frontal, maxillary, or sphenoid sinus ostia and unilateral or bilateral balloon dilation of the Eustachian tube for Commercial, Medicare, and Medicaid members in Idaho, Montana, Oregon, and Washington.

    Policy Summary
    PayerPacificSource Community Solutions
    PolicyBalloon Sinus Ostial Dilation and Eustachian Tube Dilation
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 2021
    Next Review DateMar 1, 2027
    Key ActionObtain prior authorization before balloon sinus ostial dilation or balloon dilation of the Eustachian tube.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    18+Minimum age for both covered procedures
    4 episodesMinimum recurrent acute bacterial rhinosinusitis episodes in 12 months

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    12 weeks
    Required duration for qualifying chronic sinusitis symptoms
    Once/lifetimeEustachian tube balloon dilation limit
    UnprovenUnlisted indications and Propel implant stent
    Prior authUtilization-management requirement

    Coverage Criteria

    I. Balloon Sinus Ostial Dilation

    Covered when ALL of the following are met for Commercial criteria.

    Balloon sinus ostial dilation

    • Member eligibility: Member is 18 years or older.
    • Disease pattern

      • Recurrent acute bacterial rhinosinusitis: At least four documented episodes of recurrent acute bacterial rhinosinusitis within the past 12 months.4 episodes in 12 months
      • Chronic sinusitis symptoms

        • Purulent drainage present for the past 12 weeks.
        • Nasal obstruction or congestion present for the past 12 weeks.
        • Facial symptoms: Facial pain, pressure, or fullness present for the past 12 weeks.
        • Reduced smell: Decreased sense of smell present for the past 12 weeks.
    • Failed maximal medical treatment: All of the following are required: a course of antibiotics for at least 5 to 7 days when bacterial infection is suspected and at least 6 weeks of intranasal corticosteroids.Antibiotics 5–7 days when indicated; intranasal corticosteroids 6 weeks
    • Objective disease findings: Diagnostic evaluation by nasal endoscopy or computed tomography documents one or more significant disease findings.At least 1 finding

      Qualifying findings include air-fluid levels on CT, diffuse opacification, mucosal thickening, nasal mucocele, nasal ostial obstruction, or pansinusitis.

    • Permitted sinus sites: Balloon sinus ostial dilation is limited to the frontal, maxillary, or sphenoid sinuses.Frontal, maxillary, or sphenoid sinus

    II. Balloon Dilation of the Eustachian Tube (BDET)

    Covered when ALL of the following are met for Commercial criteria.

    Balloon dilation of the Eustachian tube

    • Member eligibility: Member is 18 years or older.
    • Qualifying symptoms: At least one of the following symptoms has been present for at least the past three months: aural fullness, aural pressure, hearing loss, or autophony.1 or more symptoms for at least 3 months
    • Supporting history: History of chronic ear disease, such as chronic otitis media or cholesteatoma, OR intolerance to barometric changes for more than three months.More than 3 months when barometric intolerance is used

    Medicare

    Medicare coverage follows CMS guidelines and criteria; when CMS guidance is absent, the Commercial criteria apply.

    Medicare coverage pathway: Apply CMS guidelines and criteria. In the absence of CMS guidelines and criteria, apply the PacificSource Commercial criteria for coverage and medical necessity of balloon sinus ostial dilation and balloon dilation of the Eustachian tube.

    Medicaid

    Medicaid determinations follow applicable Oregon rules and coverage guidance, with EPSDT review requirements when applicable.

    Medicaid coverage framework

    • EPSDT beneficiaries: For EPSDT beneficiaries, apply the EPSDT coverage requirements in OAR 410-151-0002 through OAR 410-151-0003. Complete a case-by-case review of EPSDT medical necessity and medical appropriateness before denying coverage.

      Refer to the EPSDT policy for details.

    Experimental/Investigational/Unproven

    The following services or indications are experimental, investigational, and unproven.

    Experimental, investigational, and unproven services or indications: Propel Bioabsorbable Steroid-Releasing Sinus Implant Stent; balloon sinus ostial dilation for all indications not listed in the covered criteria; and balloon dilation of the Eustachian tube for all indications not listed in the covered criteria.

    Items on the experimental, investigational, and unproven list are subject to medical-necessity review guidelines for PacificSource Community Solutions and PacificSource Medicare.

    Balloon sinus ostial dilation is limited to the frontal, maxillary, or sphenoid sinuses. Dilation of other sinus sites is not included within the covered indications.

    The Propel Bioabsorbable Steroid-Releasing Sinus Implant Stent is considered experimental, investigational, and unproven. Balloon sinus ostial dilation and balloon dilation of the Eustachian tube for indications not listed in the covered criteria are also considered experimental, investigational, and unproven.

    Coding Information

    Coding InformationCPT | HCPCS
    31295Nasal/sinus endoscopy, Surgical: with Dilation of maxillary sinus ostium (e.g., balloon dilation), transnasal or Via Canine Fossa
    31296Nasal/sinus endoscopy, Surgical: with Dilation of Frontal Sinus Ostium (e.g., balloon dilation)
    31297Nasal/sinus endoscopy, Surgical: with Dilation of Sphenoid sinus ostium (e.g., balloon dilation)
    31298Nasal/sinus endoscopy, surgical; with dilation of frontal and sphenoid sinus ostia (e.g., balloon dilation)
    31299Unlisted procedure, accessory sinuses
    69705Nasopharyngoscopy, surgical, with dilation of eustachian tube (e.g., balloon dilation); unilateral
    69706Nasopharyngoscopy, surgical, with dilation of eustachian tube (e.g., balloon dilation); bilateral
    C2625Stent, noncoronary, temporary, with delivery system
    S1091Stent, noncoronary, temporary, with delivery system (Propel)

    Provider Actions and Documentation

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for balloon sinus ostial dilation and balloon dilation of the Eustachian tube(s).

    Step Therapy

    Sinusitis Medical-Treatment Trial

    Document that the member has failed maximal medical treatment before balloon sinus ostial dilation is considered medically necessary for medically refractory sinusitis.

    • At least 5 to 7 days of antibiotics when bacterial infection is suspected.
    • At least 6 weeks of intranasal corticosteroids.
    Step Therapy

    Eustachian Tube Medical-Treatment Trial

    Before BDET, document failure, intolerance, or contraindication to medical management, including at least 4 weeks of a nasal steroid spray.

    Clinical Background

    Rhinosinusitis is inflammation of the paranasal sinuses and may be acute, recurrent acute, or chronic. Balloon sinus ostial dilation widens a sinus opening to help restore drainage in members with persistent symptoms despite medical therapy. Eustachian tube dysfunction involves impaired opening or closing of the tube connecting the middle ear to the nasopharynx; balloon dilation is intended to widen the cartilaginous portion of the tube and relieve persistent obstruction.

    Definitions

    Acute rhinosinusitis
    DefinitionAn isolated episode lasting less than four weeks.
    Recurrent acute rhinosinusitis
    DefinitionFour or more occurrences of acute rhinosinusitis in one year.
    Chronic rhinosinusitis
    DefinitionRhinosinusitis lasting longer than 12 weeks despite medical management.
    Eustachian tube dysfunction
    Definition
    Policy Summary
    PayerPacificSource Community Solutions
    PolicyBalloon Sinus Ostial Dilation and Eustachian Tube Dilation
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 2021
    Next Review DateMar 1, 2027
    Key ActionObtain prior authorization before balloon sinus ostial dilation or balloon dilation of the Eustachian tube.
    SourceLink
    On This Page
    Coverage CriteriaCoding InformationProvider Actions and DocumentationClinical BackgroundDefinitions
    Abnormal tympanometry and examination: Tympanometry shows a type B or type C tympanogram AND examination shows an abnormal tympanic membrane, such as retraction, effusion, or perforation.Type B or C plus abnormal tympanic membrane
  1. Failed medical management: There is failure, intolerance, or contraindication to medical management, including at least four weeks of nasal steroid spray.Nasal steroid spray for 4 weeks
  2. Prior tympanostomy tube response when applicable: If the patient has a history of tympanostomy tube placement, Eustachian tube obstruction symptoms improved while the tubes were patent.

    Applicable when there is a history of tympanostomy tube placement.

  3. Lifetime frequency limit: The procedure has not been performed previously; coverage is limited to once per lifetime.Once per lifetime
    • Medical management must include at least 4 weeks of nasal steroid spray unless failure, intolerance, or contraindication is documented.
    Documentation Required

    Sinus Dilation Clinical Records

    Submit clinical records supporting medical necessity for balloon sinus ostial dilation, including the member's age, symptom history, diagnostic findings, and supporting treatment documentation.

    • Member is 18 years or older.
    • Document either at least 4 episodes of recurrent acute bacterial rhinosinusitis within the past 12 months, or at least 2 qualifying chronic sinusitis symptoms present for the past 12 weeks: purulent drainage, nasal obstruction or congestion, facial pain-pressure-fullness, or decreased sense of smell.
    • Provide nasal endoscopy or CT findings showing significant disease, such as air-fluid levels, diffuse opacification, mucosal thickening, nasal mucocele, nasal ostial obstruction, or pansinusitis.
    • Document that dilation is limited to the frontal, maxillary, or sphenoid sinuses.
    Documentation Required

    Failed Maximal Medical Treatment

    Document the required failed maximal medical treatment when submitting a balloon sinus ostial dilation request.

    • Antibiotics for at least 5 to 7 days if bacterial infection is suspected.
    • Intranasal corticosteroids for at least 6 weeks.
    Documentation Required

    Eustachian Tube Dilation Clinical Records

    Submit clinical records supporting chronic obstructive Eustachian tube dysfunction and BDET medical necessity.

    • Member is 18 years or older.
    • At least one qualifying symptom—aural fullness, aural pressure, hearing loss, or autophony—has been present for at least 3 months.
    • Document a history of chronic ear disease, such as chronic otitis media or cholesteatoma, or intolerance to barometric changes for more than 3 months.
    • Provide abnormal tympanometry: type B or significantly negative-pressure type C, together with an abnormal tympanic membrane examination such as retraction, effusion, or perforation.
    • Document failure, intolerance, or contraindication to medical management, including at least 4 weeks of nasal steroid spray.
    Documentation Required

    Prior Tympanostomy Tube Response

    If the patient has a history of tympanostomy tube placement, document that symptoms of Eustachian tube obstruction improved while the tubes were patent.

    • Include relevant operative, clinical, or follow-up records demonstrating symptom improvement during tube patency.
    Note

    Medicaid EPSDT Review

    For Medicaid EPSDT beneficiaries, provide the information needed for an individual case-by-case review of EPSDT medical necessity and medical appropriateness before denial.

    • PCS follows EPSDT requirements under OAR 410-151-0002 through 410-151-0003.
    • Submit clinical information relevant to medical necessity and medical appropriateness under OAR 410-151-0001 and applicable coverage guidance, including HERC Guideline Note 35.
    • A case-by-case EPSDT review is required before denying coverage; refer to the EPSDT policy for details.
    Denial Risk

    Failure to Meet Medical-Necessity Criteria

    Coverage may be denied when any applicable medical-necessity criterion is not met. Ensure the submitted records address every required criterion for the requested procedure.

    • Sinus ostial dilation requires all applicable age, symptom, treatment-trial, diagnostic, and anatomic-site criteria.
    • BDET requires all applicable age, symptom-duration, chronic ear disease or barometric-intolerance, tympanometry, medical-management, and tympanostomy-tube-response criteria.
    Denial Risk

    Unlisted Indications or Propel Stent

    Balloon sinus ostial dilation for indications not listed in the policy and balloon dilation of the Eustachian tube(s) for indications not listed above are experimental, investigational, and unproven. The Propel Bioabsorbable Steroid-Releasing Sinus Implant Stent is also experimental, investigational, and unproven.

    • Unlisted indications are not covered as medically necessary under this policy.
    • Propel stent placement is experimental, investigational, and unproven.
    Billing Rule

    Lifetime Frequency Limit

    Balloon dilation of the Eustachian tube(s), whether unilateral or bilateral, is covered only once per lifetime when all applicable medical-necessity criteria are met.

    • Apply the lifetime frequency limit to BDET requests.
    A condition in which the narrow tubes connecting the middle ear to the back of the throat fail to open or close properly.